Skip to content. | Skip to navigation

Garvan Institute

Sections
 

Professor Don Chisholm

 

Senior Principal Research Fellow; Group Leader, Diabetes and Obesity Clinical Studies, Diabetes and Obesity Research Program, Garvan Institute of Medical Research; Professor of Medicine, The University of New South Wales; Staff Endocrinologist, St Vincent's Hospital, Sydney

Email: d.chisolm 'at' garvan.org.au
Research Group: Chisholm

 
 

Education

1973 FRACP
1967 MRACP
1964 MB, BS (Honours) - Robin May Memorial Prize
1957-1963 Faculty of Medicine, University of Sydney

Awards and Honours

2002 Kellion Award, Australian Diabetes Society
1999 Officer, General Division of the Order of Australia
1998 The College Medal; Awarded for outstanding service to the College by the Royal Australasian College of Physicians
1995 Sir Kempson Maddox Award; Diabetes Australia (NSW)

Publications

Greenfield JR, Samaras K, Chisholm DJ. Insulin resistance, intra-abdominal fat, cardiovascular risk factors and androgens in healthy young women with Type 1 diabetes mellitus. J Clin Endocrinol Metab 2002; 87:1036-1040.

Ellis BA, Poynten A, Lowy A, Furler SM, Chisholm DJ, Kraegen EW, Cooney GJ. Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle. Am J Physiol (Endocrinol Metab) 2000; 279:E554-E560.

Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA. Diagnosis, prediction and natural course of HIV-1 protease-inhibitor-associated lipodustrophy, hyperlipidaemia and diabetes mellitus: a cohort study. The Lancet 1999; 353:2093-2099.

Markovic TP, Campbell LV, Balasubramanian S, Jenkins AB, Fleury AC, Simons L, Chisholm DJ. Beneficial effect on average lipid levels from energy restriction and fat loss in obese individuals with or without Type 2 diabetes. Diabetes Care 1998; 21:695-700.

Carr A, Samaras K, Chisholm DJ, Cooper DA. Pathogenesis of HIV protease inhibitor-associated syndrome of peripheral lipodystrophy, hyperlipiaemia and insulin resistance. The Lancet 1998; 351:1881-1883.

Markovic TP, Jenkins AB, Campbell LV, Furler SM, Kraegen EW, Chisholm DJ. The determinants of glycaemic responses to diet restriction and weight loss in obesity and NIDDM. Diabetes Care 1998; 21:687-694.

Oakes ND, Bell KS, Furler SM, Camilleri S, Saha AK, Ruderman NB, Chisholm DJ, Kraegen EW. Diet-induced muscle insulin resistance in rats is ameliorated by acute dietary lipid withdrawal or a single bout of exercise. Diabetes 1997; 46:2022-2028.

Carey DG, Jenkins AB, Campbell LV, Freund J, Chisholm DJ. Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes 1996; 45:633-638.

Carey DGP, Campbell LV, Chisholm DJ, Nguyen TV, Kelly P. Genetic influences on central abdominal fat: a twin study. Int J Obesity 1996; 20:722-726.

Borkman M, Storlien LH, Pan DA, Jenkins AB, Chisholm DJ, Campbell LV. The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. New Engl J Med 1993; 328:238-244.


Search for all publications by DJ Chisholm

 
 
 

Areas of Interest

Diabetes mellitus, carbohydrate metabolism, type 2 diabetes, insulin resistance, fat metabolism, muscle triglycerides, obesity
 

News

 

New Fellowship Strengthens Garvan Potential to find a cure for Type 2 diabetes

MEDIA RELEASE: 06 Dec 2007
We are very pleased to announce the establishment of the GlaxoSmithKline Don Chisholm Fellowship for Diabetes Research – a position dedicated to vital research into the causes, processes and treatments for Type 2 diabetes, one of Australia’s most common and serious diseases.
 
 

Marcia Shines For Garvan

21 Sep 2007
At the 2007 Garvan Chairman’s Dinner held on 18 September, Marcia Hines thrilled our guests with exquisite renditions of some of her greatest hits in honour of Professor Don Chisholm – a leader in diabetes research and care for over 40 years….
 
 

Personal tools